We are live on ! Find out more
CHNG

Change Healthcare Inc. Common Stock

Delisted

CHNG was delisted on the 30th of September, 2022.

263 hedge funds and large institutions have $9.08B invested in Change Healthcare Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 97 increasing their positions, 86 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2030 (+10)

27% more capital invested

Capital invested by funds: $7.17B → $9.08B (+$1.91B)

13% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 86

12% less funds holding

Funds holding: 298263 (-35)

48% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 71

53% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $29.2M

Holders
263
Holders Change
-35
Holders Change %
-11.74%
% of All Funds
4.53%
Holding in Top 10
30
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+50%
% of All Funds
0.52%
New
37
Increased
97
Reduced
86
Closed
71
Calls
$13.6M
Puts
$29.2M
Net Calls
-$15.6M
Net Calls Change
-$20.8M
Name Holding Trade Value Shares
Change
Change in
Stake
ER
301
EVR Research
Virginia
-$1.78M -77,000 Closed
Walleye Trading
302
Walleye Trading
New York
-$1.86M -75,181 Closed
QT
303
Quantbot Technologies
New York
-$1.69M -73,449 Closed
AG
304
Algert Global
California
-$1.46M -63,453 Closed
M
305
Murchinson
Ontario, Canada
-$1.46M -63,400 Closed
PFMU
306
Privium Fund Management (UK)
United Kingdom
-$1.38M -60,000 Closed
MTCM
307
Mint Tower Capital Management
Netherlands
-$1.15M -50,000 Closed
OR
308
Olympiad Research
Connecticut
-$973K -42,194 Closed
CSS
309
Cubist Systematic Strategies
Connecticut
-$812K -35,197 Closed
GCM
310
Graham Capital Management
Connecticut
-$767K -33,299 Closed
DC
311
Diametric Capital
Massachusetts
-$749K -32,491 Closed
BPGAM
312
BTG Pactual Global Asset Management
Bermuda
-$721K -31,285 Closed
Cambridge Investment Research Advisors
313
Cambridge Investment Research Advisors
Iowa
-$550K -23,839 Closed
Walleye Capital
314
Walleye Capital
New York
-$511K -22,144 Closed
RA
315
Ramius Advisors
New York
-$461K -20,000 Closed
MFS
316
Mirabella Financial Services
United Kingdom
-$401K -17,370 Closed
Comerica Bank
317
Comerica Bank
Texas
-$345K -14,511 Closed
IIM
318
INTECH Investment Management
Florida
-$328K -14,235 Closed
GAM
319
Gotham Asset Management
New York
-$305K -13,212 Closed
Canada Life
320
Canada Life
Manitoba, Canada
-$283K -12,272 Closed
CA
321
Capitolis Advisors
New York
-$227K -9,843 Closed
PM
322
Parametrica Management
Hong Kong
-$221K -9,523 Closed
GCM
323
Gladius Capital Management
Illinois
-$132K -5,709 Closed
SAM
324
S.A. Mason
Michigan
-$115K -5,000 Closed
APF
325
Alaska Permanent Fund
Alaska
-$97K -4,188 Closed

CHNG Hedge Fund Activity: Q3 2022 in Review

263 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Change Healthcare Inc. Common Stock (CHNG) for Q3 2022, worth a combined $9.08B — up 27% from $7.17B a quarter earlier.

Sellers outnumbered buyers: 71 funds closed out of CHNG and 37 opened new positions — a net loss of 34 holders — while 86 trimmed existing stakes and 97 added.

The largest buyer was Farallon Capital Management, adding an estimated $196M. The largest seller was Morgan Stanley, cutting an estimated $120M.

  • 263 institutional investors held Change Healthcare Inc. Common Stock (CHNG) as of Q3 2022, down from 298 in Q2 2022.
  • Funds reported $9.08B of Change Healthcare Inc. Common Stock stock for Q3 2022, up 27% quarter-over-quarter.
  • 37 funds opened new Change Healthcare Inc. Common Stock positions in Q3 2022 and 71 closed out, a net change of -34 holders.
  • The largest Change Healthcare Inc. Common Stock buyer in Q3 2022 was Farallon Capital Management, an estimated $196M added.
  • The largest Change Healthcare Inc. Common Stock seller in Q3 2022 was Morgan Stanley, an estimated $120M sold.

Based on aggregated 13F filings for Q3 2022.